For the quarter ending 2026-03-31, COCP has $7,426K in assets. $3,310K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 4,685 | 7,025 | 7,729 | 4,766 |
| Restricted cash | 75 | 75 | 75 | 75 |
| Grant receivable | 70 | - | - | - |
| Tax credit receivable | 691 | 706 | 513 | 1,642 |
| Prepaid expenses and other current assets | 418 | 328 | 465 | 282 |
| Total current assets | 5,939 | 8,134 | 8,782 | 6,765 |
| Total property and equipment | 2,094 | 2,094 | 2,094 | - |
| Less accumulated depreciation and amortization | 2,013 | 2,001 | 1,988 | - |
| Property and equipment, net | 81 | 93 | 106 | 107 |
| Deposits | 95 | 95 | 90 | 88 |
| Operating lease right of use assets related party | 1,311 | 1,390 | 1,468 | 1,545 |
| Total assets | 7,426 | 9,712 | 10,446 | 8,505 |
| Accounts payable and accrued expenses | 1,886 | 1,876 | 1,194 | 1,514 |
| Operating lease liabilities related party current | 343 | 334 | 326 | 317 |
| Total current liabilities | 2,229 | 2,210 | 1,520 | 1,831 |
| Operating lease liabilities related party non-current | 1,081 | 1,171 | 1,257 | 1,341 |
| Total long-term liabilities | 1,081 | 1,171 | - | 1,341 |
| Total liabilities | 3,310 | 3,381 | 2,777 | 3,172 |
| Common stock, 0.001 a par value 100,000 shares authorized as of march 31, 2026 and december 31, 2025 13,787 and 13,784 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | 13 | 13 | 13 | 10 |
| Additional paid-in capital | 348,651 | 348,567 | 347,479 | 343,097 |
| Accumulated deficit | -344,548 | -342,249 | -339,823 | -337,774 |
| Total stockholders equity | 4,116 | 6,331 | 7,669 | 5,333 |
| Total liabilities and stockholders equity | 7,426 | 9,712 | 10,446 | 8,505 |
Cocrystal Pharma, Inc. (COCP)
Cocrystal Pharma, Inc. (COCP)